Are We Prescribing Enough HIV Pre-Exposure Prophylaxis in Missouri?: A Cross-Sectional Study at University of Missouri Health Care.

Despite the proven efficacy and safety of HIV pre-exposure prophylaxis (PrEP), it remains underutilized. PrEP use among Missouri providers has increased as the rate of new HIV infections grows statewide, but remains lower than the Midwest and United States (U.S.) averages. Because the Centers for Disease Control and Prevention (CDC) identify Missouri as at-risk for an HIV outbreak, we seek to characterize HIV testing practices and PrEP knowledge and use among Missouri healthcare providers.

[1]  Matias Remes,et al.  Basics. , 1978, Cue and Cut.

[2]  Rose S. Bono,et al.  HIV-Experienced Clinician Workforce Capacity: Urban-Rural Disparities in the US South. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  W. Armstrong.  The HIV Workforce in Crisis: An Urgent Need to Build the Foundation Required to End the Epidemic. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  D. Smith,et al.  Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis — United States, 2013–2018 , 2019, MMWR. Morbidity and mortality weekly report.

[5]  D. Trauner,et al.  Pre-Exposure Prophylaxis (PrEP) , 2019, Synfacts.

[6]  K. Brady,et al.  Knowledge, Attitudes, and PrEP Prescribing Practices of Health Care Providers in Philadelphia, PA , 2019, Journal of primary care & community health.

[7]  Rose S. Bono,et al.  Suboptimal geographic accessibility to comprehensive HIV care in the US: regional and urban–rural differences , 2019, Journal of the International AIDS Society.

[8]  M. Rodriguez‐Barradas,et al.  Integration of telehealth services in the healthcare system: with emphasis on the experience of patients living with HIV , 2019, Journal of Investigative Medicine.

[9]  Michael R. Kramer,et al.  Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. , 2018, Annals of epidemiology.

[10]  Michael R. Kramer,et al.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. , 2018, Annals of epidemiology.

[11]  B. Vuylsteke,et al.  Physicians' preparedness for pre-exposure prophylaxis: results of an online survey in Belgium. , 2018, Sexual health.

[12]  W. Holzemer,et al.  Support for PrEP Among New Jersey Health Care Workers , 2018, The Journal of the Association of Nurses in AIDS Care : JANAC.

[13]  D. Smith,et al.  HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016 , 2018, MMWR. Morbidity and mortality weekly report.

[14]  W. El-Sadr,et al.  Response Rates of Medical Providers to Internet Surveys Regarding Their Adoption of Preexposure Prophylaxis for HIV: Methodological Implications , 2018, Journal of the International Association of Providers of AIDS Care.

[15]  Brian R Wood,et al.  Knowledge, Practices, and Barriers to HIV Preexposure Prophylaxis Prescribing Among Washington State Medical Providers , 2018, Sexually transmitted diseases.

[16]  H. Friedman,et al.  Knowledge of HIV Testing Guidelines Among US Internal Medicine Residents: A Decade After the Centers for Disease Control and Prevention's Routine HIV Testing Recommendations , 2018, AIDS patient care and STDs.

[17]  L. Adams,et al.  Who Starts the Conversation and Who Receives Preexposure Prophylaxis (PrEP)? A Brief Online Survey of Medical Providers’ PrEP Practices , 2018, Health education & behavior : the official publication of the Society for Public Health Education.

[18]  A. Seña,et al.  Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care , 2017, Journal of acquired immune deficiency syndromes.

[19]  G. Zimet,et al.  HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre‐Exposure Prophylaxis to At‐Risk Adolescents and Adults , 2017, AIDS patient care and STDs.

[20]  J. Kelly,et al.  PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists , 2017, AIDS and Behavior.

[21]  Christopher M. Jones,et al.  County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States , 2016, Journal of acquired immune deficiency syndromes.

[22]  J. Stryker,et al.  PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009–2015 , 2016, PloS one.

[23]  P. Kelly,et al.  United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey. , 2016, Contraception.

[24]  K. Mayer,et al.  The role of healthcare providers in the roll out of preexposure prophylaxis , 2016, Current opinion in HIV and AIDS.

[25]  S. Little,et al.  Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study) , 2014, AIDS and Behavior.

[26]  P. Polgreen,et al.  Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  W. Duffus,et al.  Preexposure Prophylaxis for HIV Infection: Healthcare Providers’ Knowledge, Perception, and Willingness to Adopt Future Implementation in the Southern US , 2012, Southern medical journal.